ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

ClinicalTrials.gov ID: NCT06980805

Public ClinicalTrials.gov record NCT06980805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 10:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations

Study identification

NCT ID
NCT06980805
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Immunovant Sciences GmbH
Industry
Enrollment
56 participants

Conditions and interventions

Interventions

  • IMVT-1402 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 18, 2025
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027
Last update posted
Apr 20, 2026

2025 – 2027

United States locations

U.S. sites
33
U.S. states
13
U.S. cities
31
Facility City State ZIP Site status
Site Number - 1010 Anniston Alabama 36207-4780 Recruiting
Site Number - 1020 Birmingham Alabama 35203-4050 Recruiting
Site Number - 1038 Phoenix Arizona 85037 Recruiting
Site Number - 1034 Scottsdale Arizona 85260 Recruiting
Site Number - 1022 Beverly Hills California 90211 Recruiting
Site Number - 1018 Chula Vista California 91910 Recruiting
Site Number - 1039 Corona California 92882 Recruiting
Site Number - 1005 Fremont California 94538 Recruiting
Site Number - 1023 Los Angeles California 90045 Recruiting
Site Number - 1000 Aurora Colorado 80045-2541 Recruiting
Site Number - 1033 Castle Rock Colorado 80109-8034 Recruiting
Site Number - 1021 Farmington Connecticut 06030-2840 Recruiting
Site Number - 1014 Hialeah Florida 33012 Recruiting
Site Number - 1017 Jacksonville Florida 32256 Recruiting
Site Number - 1028 Miami Florida 33122 Recruiting
Site Number - 1024 Miami Florida 33133 Recruiting
Site Number - 1027 Miami Florida 33136 Recruiting
Site Number - 1011 Miami Lakes Florida 33014-5602 Recruiting
Site Number - 1025 Orlando Florida 32819 Recruiting
Site Number - 1009 Buford Georgia 30518-8721 Recruiting
Site Number - 1030 Brighton Massachusetts 02135 Recruiting
Site Number - 1019 Auburn Hills Michigan 48326-3396 Recruiting
Site Number - 1003 Saint Clair Shores Michigan 48081-1274 Recruiting
Site Number - 1013 Troy Michigan 48084 3536 Recruiting
Site Number - 1004 Saint Joseph Missouri 64506-2459 Recruiting
Site Number - 1026 St Louis Missouri 63104 Recruiting
Site Number - 1007 Charlotte North Carolina 28211-1064 Recruiting
Site Number - 1008 Durham North Carolina 27713-8505 Recruiting
Site Number - 1006 Smithfield North Carolina 27577-4664 Recruiting
Site Number - 1002 Hershey Pennsylvania 17033 Recruiting
Site Number - 1015 Philadelphia Pennsylvania 19103-4708 Recruiting
Site Number - 1035 Houston Texas 77030 Recruiting
Site Number - 1012 Irving Texas 75061 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06980805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06980805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →